Company Directory / Biotechnology

DelistedFor profitBiotechnologySouth San Francisco, CA, United States
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
NGM Bio is a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease. The company’s biology-centric drug discovery approach aims to seamlessly integrate interrogation of complex disease-associated biology and protein engineering expertise to unlock proprietary insights that are leveraged to generate promising product candidates and enable their rapid advancement into proof-of-concept studies. As explorers on the… Read all
NGM Bio is a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease. The company’s biology-centric drug discovery approach aims to seamlessly integrate interrogation of complex disease-associated biology and protein engineering expertise to unlock proprietary insights that are leveraged to generate promising product candidates and enable their rapid advancement into proof-of-concept studies. As explorers on the frontier of life-changing science, NGM Bio aspires to operate one of the most productive research and development engines in the biopharmaceutical industry. All therapeutic candidates in the NGM Bio pipeline have been generated by its in-house discovery engine, always led by biology and motivated by unmet patient need. In addition to a healthy balance sheet and cash runway, the company currently has four programs in active clinical development. Visit us at www.ngmbio.com for more information.
Size
101-250 people: larger than 85% of companies with a size listed. 130 people list it on LinkedIn.
Age
19 years old.
Reach
Website ranked #3,941,710 in the world for traffic, about 3k visits a month. 10,121 followers on LinkedIn.
BiopharmaBiotechnologyGeneticsMedical
Funding, as listed
$542M raised in total
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about NGM Biopharmaceuticals, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
NGM Biopharmaceuticals may be growing as indicated by the increase in its share price, which shareholders have positively noted. The company's stock has experienced a significant bounce, reflecting investor confidence and potentially positive company performance. This share price growth is a key indicator of market sentiment and can be associated with positive financial health or expectations.
Summaries written by the source dataset, not by us, and not checked.
Biotechnology in United States.
InsmedBridgewater Township · 501-1000 people · 51k followersSSAGE TherapeuticsCambridge · 501-1000 people · 111k followers
InvitaeSan Francisco · 1001-5000 people · 146k followers
Amicus TherapeuticsPrinceton · 501-1000 people · 48k followers
GrailMenlo Park · 1001-5000 peopleFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.